-
Loading metrics
Open Access
Peer-reviewed
Research Article
Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy
-
Jiri Minarik ,
* E-mail: abretina@email.cz
Affiliation Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic
⨯ -
Petr Pavlicek,
Affiliation Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Praha, Czech Republic
⨯ -
Ludek Pour,
Affiliation Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
⨯ -
Tomas Pika,
Affiliation Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic
⨯ -
Vladimir Maisnar,
Affiliation Department of Clinical Hematology, University Hospital, Hradec Kralove, Czech Republic
⨯ -
Ivan Spicka,
Affiliation Department of Internal Medicine, University Hospital, Praha, Czech Republic
⨯ -
Jiri Jarkovsky,
Affiliation Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
⨯ -
Marta Krejci,
Affiliation Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
⨯ -
Jaroslav Bacovsky,
Affiliation Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic
⨯ -
Jakub Radocha,
Affiliation Department of Clinical Hematology, University Hospital, Hradec Kralove, Czech Republic
⨯ -
Jan Straub,
Affiliation Department of Internal Medicine, University Hospital, Praha, Czech Republic
⨯ -
Petr Kessler,
Affiliation Department of Hematology and Transfusion, General Hospital, Pelhrimov, Czech Republic
⨯ -
Marek Wrobel,
Affiliation Department of Oncology, Hospital Novy Jicin, Novy Jicin, Czech Republic
⨯ -
Lenka Walterova,
Affiliation Department of Clinical Hematology, General Hospital Liberec, Liberec, Czech Republic
⨯ -
Michal Sykora,
Affiliation Department of Clinical Hematology, General Hospital, Ceske Budejovice, Czech Republic
⨯ -
Jarmila Obernauerova,
Affiliation Department of Hematology and Transfusion, Claudian Hospital, Mlada Boleslav, Czech Republic
⨯ -
Lucie Brozova,
Affiliation Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
⨯ -
Evzen Gregora,
Affiliation Department of Clinical Hematology, University Hospital Kralovske Vinohrady, Praha, Czech Republic
⨯ -
Dagmar Adamova,
Affiliation Department of Hematology and Transfusiology, Silesian Hospital, Opava, Czech Republic
⨯ -
Jaromir Gumulec,
Affiliation Department of Haematooncology, University Hospital Ostrava and the Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
⨯ -
Zdenek Adam,
Affiliation Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
⨯ -
Vlastimil Scudla,
Affiliation Department of Hemato-oncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic
⨯ -
Roman Hajek,
Affiliation Department of Haematooncology, University Hospital Ostrava and the Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
⨯ - [ ... ],
- for the Czech Myeloma Group
- [ view all ]
- [ view less ]
Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy
- Jiri Minarik,
- Petr Pavlicek,
- Ludek Pour,
- Tomas Pika,
- Vladimir Maisnar,
- Ivan Spicka,
- Jiri Jarkovsky,
- Marta Krejci,
- Jaroslav Bacovsky,
- Jakub Radocha
- Published: April 14, 2015
- https://doi.org/10.1371/journal.pone.0123866